Genes vs environment in inflammatory bowel disease: an update

被引:10
作者
Dipasquale, Valeria [1 ]
Romano, Claudio [1 ]
机构
[1] Univ Messina, Pediat Gastroenterol & Cyst Fibrosis Unit, Dept Human Pathol Adulthood & Childhood G Barresi, Via Consolare Valeria 1, I-98124 Messina, Italy
关键词
Environment; gene; inflammatory bowel disease; risk factor; very early onset inflammatory bowel disease; CROHNS-DISEASE; ULCERATIVE-COLITIS; PEDIATRIC GASTROENTEROLOGY; WIDE ASSOCIATION; RECENT INSIGHTS; ACTIVE DISEASE; POSITION PAPER; TWIN COHORT; FOLLOW-UP; RISK;
D O I
10.1080/1744666X.2022.2108407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction Inflammatory bowel diseases (IBDs) are known to be caused by a combination of genetic and environmental factors that vary in their influence on the development of the disease. Environmental exposures seem to influence IBD susceptibility, whereas genetic background is thought to modulate the impact of the environment on disease course and phenotype. Areas covered A broad review of the involvement of genes and the environment in IBD pathogenesis was performed, and information regarding the main genetic and environmental factors - categorized into lifestyle factors, drugs, diet, and microbes - was updated. Monogenic very early onset IBD (VEO-IBD) was also discussed. Expert opinion In the upcoming years, better understanding of gene-environment interactions will contribute to the possibility of a better prediction of disease course, response to therapy, and therapy-related adverse events with the final goal of personalized and more efficient patient management.
引用
收藏
页码:1005 / 1013
页数:9
相关论文
共 50 条
[41]   New biologics and small molecules in inflammatory bowel disease: an update [J].
Sabin, Joao ;
Verstockt, Bram ;
Vermeire, Severine ;
Ferrante, Marc .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
[42]   The risk for opportunistic infections in inflammatory bowel disease with biologics: an update [J].
Borman, Zachary A. ;
Cote-Daigneault, Justin ;
Colombel, Jean-Frederic .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (11) :1101-1108
[44]   Update on inflammatory bowel disease in patients with primary sclerosing cholangitis [J].
Christos Tsaitas ;
Anysia Semertzidou ;
Emmanouil Sinakos .
World Journal of Hepatology, 2014, (04) :178-187
[45]   Advanced multimodality imaging of inflammatory bowel disease in 2015: An update [J].
Stanley, Emma ;
Moriarty, Heather K. ;
Cronin, Carmel G. .
WORLD JOURNAL OF RADIOLOGY, 2016, 8 (06) :571-580
[46]   Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update [J].
Tan, Pufang ;
Li, Xiaogang ;
Shen, Jun ;
Feng, Qi .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[47]   Update on the Heritability of Inflammatory Bowel Disease: The Importance of Twin Studies [J].
Brant, Steven R. .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) :1-5
[48]   Genes, diet and inflammatory bowel disease [J].
Ferguson, Lynnette R. ;
Shelling, Andrew N. ;
Browning, Brian L. ;
Huebner, Claudia ;
Petermann, Ivonne .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2007, 622 (1-2) :70-83
[49]   HLA-DQ: Celiac disease vs inflammatory bowel disease [J].
Marta Maia Bosca-Watts ;
Miguel Minguez ;
Dolores Planelles ;
Samuel Navarro ;
Alejandro Rodriguez ;
Jesus Santiago ;
Joan Tosca ;
Francisco Mora .
World Journal of Gastroenterology, 2018, 24 (01) :96-103
[50]   HLA-DQ: Celiac disease vs inflammatory bowel disease [J].
Maia Bosca-Watts, Marta ;
Minguez, Miguel ;
Planelles, Dolores ;
Navarro, Samuel ;
Rodriguez, Alejandro ;
Santiago, Jesus ;
Tosca, Joan ;
Mora, Francisco .
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (01) :96-103